高级检索
当前位置: 首页 > 详情页

A Study Based on the Correlation Between Slit2/Robo1 Signaling Pathway Proteins and Polymyositis/Dermatomyositis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Qinghai Univ, Dept Rheumatism & Immunol, Affiliated Hosp, 29 Tongren Rd, Xining 810001, Qinghai, Peoples R China [2]Peoples Hosp SND, Dept Rheumatism & Immunol, Suzhou 215219, Peoples R China [3]Hebei Univ, Dept Rheumatism & Immunol, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China [4]Sichuan Univ, West China Sch Med, Dept Med Imaging Technol, Chengdu 610041, Peoples R China [5]Sichuan Univ, West China Hosp, Chengdu 610041, Peoples R China
出处:
ISSN:

关键词: Polymyositis Dermatomyositis Slit2 Robo1 inflammation signaling pathway

摘要:
Aims: To investigate the role of Slit2 and Robo1 during the vascular disease of Polymyositis (PM) / dermatomyositis (DM). Background: PM and DM are nonsuppurative inflammatory myopathies that mainly invade the skeletal muscles. Objective: This study attempted to explore the specific mechanism of Slit2/Robo1 signaling pathway proteins during the vascular disease of PM/DM. Methods: The mRNA expressions of Slit2 and Robot in the muscle tissue were detected by RT-qPCR between newly-diagnosed PM/DM patients and healthy controls. The number of Slit2 and Robo1 positive cells in the serial sections of muscle paraffin tissues was measured by immunohistochemistry in 10 patients with PM, 10 patients with DM and 20 healthy controls. Results: The study results revealed that the mRNA expressions of Slit2 and Robo1 in muscle tissue in the PM and DM groups were higher than that in the control group (P<0.05). The positive expression rates of Slit2 and Robo1 in muscle tissue in the PM and DM groups were 80.0%, 80.0%, 70.0% and 70.0%, respectively. The difference was statistically significant (P<0.001), when compared to the control group (the positive expression rates were 0% and 10%, respectively). Conclusion: The activation of the Slit2/Robo1 signaling pathway is an important mechanism leading to the development of PM/DM.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
JCR分区:
出版当年[2020]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Qinghai Univ, Dept Rheumatism & Immunol, Affiliated Hosp, 29 Tongren Rd, Xining 810001, Qinghai, Peoples R China [*1]Department of Rheumatism and Immunology, Affiliated Hospital of Qinghai University, NO.29 of Tongren Road, Chengxi District, Xining 810001, China
通讯作者:
通讯机构: [1]Qinghai Univ, Dept Rheumatism & Immunol, Affiliated Hosp, 29 Tongren Rd, Xining 810001, Qinghai, Peoples R China [*1]Department of Rheumatism and Immunology, Affiliated Hospital of Qinghai University, NO.29 of Tongren Road, Chengxi District, Xining 810001, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15714 今日访问量:0 总访问量:1038 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号